Market Tracker

04/17 6:05pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

78.82
Data as of Apr 17
 -0.48 / -0.60%
Today’s Change
38.58
Today|||52-Week Range
119.42
+21.79%
Year-to-Date

Today’s Trading

Previous close79.38
Today’s open78.89
Day’s range76.28 - 81.78
Volume162,726
Average volume (3 months)308,472
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-84.67%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book5.72

Competitors

 Today’s
change
Today’s
% change
ITMNInterMune Inc-0.02-0.07%
XONIntrexon Corp-0.35-1.78%
AEGRAegerion Pharmaceuti...-0.09-0.21%
IMGNImmunoGen Inc-0.22-1.55%
Data as of 4:01pm ET, 04/17/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Financial Officer &
Senior Vice President
Carsten Boess
Corporate headquarters
Lexington, Massachusetts

Forecasts